Diagnosis and management of catheter-related infections in the ICU;Diagnostic et prise en charge des infections sur cathéter en réanimation

Medecine et Maladies Infectieuses

Volumn 33, Issue 12, 2003, Pages 619-627

  Timsit, J F ^a   Wolff, M ^a   Mourvillier, B ^a   Schortgen, F ^a   Regnier B ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Central venous catheter infection; Diagnosis; Treatment

Indexed keywords

ANTIBIOTIC AGENT;

BACTEREMIA; BLOOD CULTURE; CANDIDA; CATHETER INFECTION; CELLULITIS; CENTRAL VENOUS CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE SEVERITY; ENDOCARDITIS; ENTEROBACTERIACEAE; FEVER; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; MICROORGANISM; PROSTHESIS; PSEUDOMONAS AERUGINOSA; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; THROMBOPHLEBITIS; TREATMENT PLANNING; VIRULENCE;

EID: 0347519021     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(03)00237-3     Document Type: Review

References (51)

1. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155:1177-84.
2. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001;163:1584-90.
3. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. Jama 1994;271:1598-601.
4. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976-81.
5. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027-30.
6. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999;20:396-401.
7. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993;16:778-84.
8. Safdar N, Maki DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 2002;30:2632-5.
9. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977;296:1305-9.
10. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 1987;147:873-7.
11. Siegman-Igra Y, Anglim AM, Shapiro DE, Adal KA, Strain BA, Farr BM. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997;35:928-36.
12. e conférence de consensus de la S.R.L.F. Infections liées aux cathéters veineux centraux en réanimation. Réanimation 2003;12:258-65.
13. Rijnders BJ, Van Wijngaerden E, Peetermans WE. Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence? Clin Infect Dis 2002;35:1053-8.
14. Guidet B, Nicola I, Barakett V, Gabillet JM, Snoey E, Petit JC, et al. Skin vs hub cultures to predict colonization and infection of central venous catheter in intensive care patients. Infection 1994;22:43-8.
15. Mosca R, Curtas S, Forbes B, Meguid MM. The benefits of Isolator cultures in the management of suspected catheter sepsis. Surgery 1987;102:718-23.
16. Quilici N, Audibert G, Conroy MC, Bollaert PE, Guillemin F, Welfringer P, et al. Differential quantitative blood cultures in the diagnosis of catheter-related sepsis in intensive care units. Clin Infect Dis 1997;25:1066-70.
17. Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S, et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood vs peripheral-blood cultures. Lancet 1999;354:1071-7.
18. Blot F, Schmidt E, Nitenberg G, Tancrede C, Leclercq B, Laplanche A, et al. Earlier positivity of central-venous- vs peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998;36:105-9.
19. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, et al. Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2001;22:222-42.
20. Rex JH, Bennett JE, Sugar AM, Pappas PG, Serody J, Edwards JE, et al. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis 1995;21:994-6.
21. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:662-78.
22. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis 2002;34:591-9.
23. Malanoski GJ, Samore MH, Pefanis A, Karchmer AW. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995;155:1161-6.
24. Fowler Jr. VG, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998;27:478-86.
25. Capdevilla JA, Segarra A, Planes AM, Gasser I, Gavalda J, Valverde PR, et al. Long term follow up of patients with catheter-related bacteremia treated without catheter removal. Clin Microbiol Infect 1998;4:472-6.
26. Rubin LG, Shih S, Shende A, Karayalcin G, Lanzkowsky P. Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal. Clin Infect Dis 1999;29:102-5.
27. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997;127:275-80.
28. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990;69:296-306.
29. Capdevila JA, Segarra A, Planes AM, Ramirez-Arellano M, Pahissa A, Piera L, et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 1993;8:231-4.
30. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995;74:340-9.
31. Sandoe JA, Witherden IR, Au-Yeung HK, Kite P, Kerr KG, Wilcox MH. Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases. J Antimicrob Chemother 2002;50:577-82.
32. Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992;13:215-21.
33. Cook D, Randolph A, Kernerman P, Cupido C, King D, Soukup C, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997;25:1417-24.
34. Nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995;21:1417-23.
35. Timsit JF, Bruneel F, Cheval C, Mamzer MF, Garrouste-Orgeas M, Wolff M, et al. Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann Intern Med 1999;130:729-35.
36. Vidal F, Mensa J, Almela M, Martinez JA, Marco F, Casals C, et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med 1996;156:2121-6.
37. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002;347:2020-9.
38. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002;46:1773-80.
39. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002;46:3634-6.
40. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002;46:3591-6.
41. Lewis RE, Kontoyiannis DP, Darouiche RO, Raad II, Prince RA. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother 2002;46:3499-505.
42. Brion JP. Place du verrou antibiotique dans le traitement des infections de chambre à cathéter implantable. Med Mal Infect 1998;28:461-8.
43. Jernigan JA, Farr BM. Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med 1993;119:304-11.
44. Fry DE, Fry RV, Borzotta AP. Nosocomial blood-borne infection secondary to intravascular devices. Am J Surg 1994;167:268-72.
45. Fowler Jr. VG, Li J, Corey GR, Boley J, Marr KA, Gopal AK, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997;30:1072-8.
46. Verghese A, Widrich WC, Arbeit RD. Central venous septic thrombophlebitis-the role of medical therapy. Medicine (Baltimore) 1985;64:394-400.
47. Ayzac L, Callat-Vallet E, Savey A, Lepape A, Fabry J, Est CS. Rapport annuel du réseau de surveillance des infections nosocomiales en réanimation 2001. 2000.
48. Ayzac L, Callat-Vallet E, Savey A, Lepape A, Fabry J. CCLIN Sud-Est. Rapport annuel du réseau de surveillance des infections nosocomiales en réanimation. http://cclin-sudest.univ-lyon1.fr/surveillance/Reseaux/REA/Outil00rea/ rap2000rea.pdf. 2001.
49. REACAT. Réseau de surveillance des infections liées au cathéters veineux centraux dans les services de réanimation adulte: données de surveillance REACAT. http://www.ccr.jussieu.fr/cclin/welcomebis.htm. 2001.
50. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999;27:520-32.
51. Wolff M. Infections liées aux cathéters veineux en réanimation: stratégies thérapeutiques. Actualités en réanimation et urgences 2001. Paris: Esem Elsevier; 2001. p. 31-42.